Lv4
800 积分 2023-06-30 加入
Pembrolizumab plus weekly paclitaxel in platinum-resistant recurrent ovarian cancer (ENGOT-ov65/KEYNOTE-B96): a multicentre, randomised, double-blind, phase 3 study
6天前
已完结
Therapeutic targets and new directions for antibodies developed for ovarian cancer
6天前
已完结
Targeted Therapy in Ovarian Cancer
7天前
已完结
Ovarian cancer
8天前
已完结
Efficacy and Safety of Tezepelumab in Adults With Severe, Uncontrolled Asthma in Asia: Results From the Phase 3 DIRECTION Study
15天前
已完结
Biologics for severe asthma—Which, when and why?
15天前
已完结
Prevalence, risk factors, and management of asthma in China: a national cross-sectional study
17天前
已完结
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
18天前
已完结
Expression profiles of cadherin 17 and claudin 18.2 in comparison with peptide hormonal expression in pancreatic neuroendocrine tumours: Implications for targeted immunotherapy
20天前
已完结
Efficacy and safety of first-line targeted and immunotherapy for metastatic colorectal cancer: a network meta-analysis
1个月前
已完结
皖公网安备34019202002308
